National Brain Tumor Society is fiercely committed to finding better treatments, and ultimately a cure, for people living with a brain tumor today and anyone who will be diagnosed tomorrow.
This means effecting change in the system at all levels.

Together, We Create Real Impact

3 Legislative wins in 2012 Over 30M Raised 5 FDA treatments approved

From the Blog

  • October 6, 2015

    National Brain Tumor Society Statement on FDA Approval of Optune for Treatment of Glioblastoma Patients

    National Brain Tumor Society (NBTS) interim Chief Executive Officer David Arons issued the following statement on the U.S. Food and Drug Administration’s (FDA) approval yesterday of Novocure’s Optune, a medical device to treat newly diagnosed glioblastoma multiforme (GBM) patients in combination with the chemotherapy temozolomide (brand name: Temodar) following standard treatment of surgery an

    Read More

  • October 1, 2015

    CCAM and NBTS: A recap of pediatric brain tumor news


    As another Childhood Cancer Awareness Month (CCAM) comes to a close, the National Brain Tumor Society wants to thank all of you for attending our events, sharing your stories, and doi

    Read More

  • October 1, 2015

    National Brain Tumor Society Teams Up With The V Foundation for Cancer Research To Fight Pediatric Brain Tumors

    National Brain Tumor Society, the largest nonprofit organization dedicated to the brain tumor community in the United States, today announced that it teamed up with The V Foundation for Cancer Research, one of the nation’s leading cancer research funding organizations, to fund pediatric brain tumor research. Both organizations plan to help fund a new, innovative […]

    Read More

More from the blog